Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatment

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatment
Authors
Keywords
Alemtuzumab, Multiple sclerosis, Polymorphonuclear neutrophils, Neutropenia
Journal
Multiple Sclerosis and Related Disorders
Volume 18, Issue -, Pages 181-183
Publisher
Elsevier BV
Online
2017-09-26
DOI
10.1016/j.msard.2017.09.028

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.